Further, we demonstrated that NE inhibitors, sivelestat sodium hydrate and human SERPINB1 recombinant protein, protected against OALT-induced ALI by improving pulmonary antioxidant properties and reducing damage to alveolar epithelial cells. The gene discussed is SERPINB1; the disease is acute respiratory distress syndrome.